April 2017 in “European Psychiatry” This study found that antidepressants may affect loving relationships differently by gender, with women on TCAs experiencing more sexual side effects and men on SSRIs reporting reduced feelings of love and attachment.
April 2025 in “Cancer Research” This study examined older adults undergoing chemotherapy and found that nutritional-inflammatory biomarker ratios were significantly linked to cognitive impairments, treatment side effects, and quality of life indicators, suggesting these lab measurements might help identify high-risk individuals for intervention.
February 2026 in “BMJ Open” This study found that the most significant negative emotional responses among cancer patients during consultations were related to treatment delays and the possibility of hair loss.
14 citations
,
January 2013 in “International Journal of Trichology” This review discusses physician-patient dynamics in managing hair loss and highlights the emotional impacts, emphasizing the need for effective communication and patient education, but it reports no new clinical findings.
11 citations
,
August 2017 in “Supportive care in cancer” This study highlights the significant impact of eyebrow and eyelash loss during chemotherapy on women's quality of life, noting both emotional and physical challenges.
May 2017 in “Urology and andrology” Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.
July 2008 in “International journal of psychophysiology” This retrospective study found that cyproterone acetate, both alone and with estrogens, was safe, well tolerated, and induced modest feminizing effects in late-pubertal transgender female adolescents.
7 citations
,
May 2021 in “Seizure” This review found that antiseizure medications, particularly phenytoin and valproate, are associated with cosmetic side effects like gingival hyperplasia, hirsutism, acne, and hair loss.
June 2026 in “Quality in Sport” This narrative review analyzed the literature on premature hair graying, identifying potential contributors such as nutrient deficiencies, oxidative and emotional stress, smoking, genetic factors, autoimmune diseases, and medication side effects, but reported no effective treatment to reverse it, underscoring the necessity for further research.
2 citations
,
March 2016 in “Journal of Mind and Medical Sciences” This study observed several mild to moderate oral adverse effects during finasteride use, which generally improved with topical treatment without needing to discontinue the drug.
January 2013 in “Elsevier eBooks” This article discusses the psychological impact of hair loss from cytotoxic drugs on cancer patients and reports no new clinical findings, highlighting a need for addressing patients' emotional responses.
15 citations
,
June 2014 in “Integrative cancer therapies” This study found that an 8-week practice of pranic meditation was associated with improved quality of life and mental health scores in breast cancer survivors, though further research is needed for confirmation.
43 citations
,
January 2016 in “International Journal of Andrology” This study found that men experiencing long-term symptoms after finasteride use for androgenetic alopecia frequently reported loss of penis sensitivity and anhedonia, among other effects, indicating potential post-finasteride syndrome.
May 2026 in “Journal of Clinical Oncology” In this study, patients with advanced cancers reported significant quality of life impacts from second-line therapies, including gastrointestinal and neurological side effects, emotional distress, and social isolation, yet remained motivated to continue treatment for survival and personal connections.
June 2025 in “Patient Preference and Adherence” This study examined Chinese adult patients' discussions on social media about JAK inhibitors for alopecia areata, highlighting significant interest in these treatments but also concerns about efficacy, relapse, side effects, and the emotional impact of the condition.
This paper examines the development of scalp cooling as a non-drug method to reduce chemotherapy-induced hair loss, addressing an emotionally challenging side effect of cancer treatment. Results are not provided in the abstract.
20 citations
,
November 2013 in “The Open Cancer Journal” This observational study provides cause-specific mortality estimates to help patients and physicians better understand long-term outcomes for localized prostate cancer based on initial treatment choices.
72 citations
,
June 2017 in “Zenodo (CERN European Organization for Nuclear Research)” This article reviews conventional and alternative treatments for hair loss, noting FDA-approved drugs like Minoxidil and Finasteride, but reports no new clinical findings; the authors highlight concerns about side effects, spurring interest in herbal remedies.
7 citations
,
January 2010 in “Research journal of pharmaceutical, biological and chemical sciences” This review discusses conventional and alternative hair loss treatments, such as Minoxidil and herbal remedies, noting their effectiveness and concerns over side effects but reports no new clinical results.
2 citations
,
January 2017 This abstract reviews existing hair loss treatments, highlighting FDA-approved drugs like Minoxidil and Finasteride while noting growing interest in herbal alternatives due to concerns about potential long-term side effects.
This review discusses the potential of using sustained release systems to increase the effectiveness and reduce side effects of 17-alpha-estradiol in alopecia treatment and reports no clinical results.
204 citations
,
May 2014 in “The Journal of Sexual Medicine” This study concluded that current cross-sex hormone treatments for trans men and trans women are effective with a low risk of side effects in the short term, though they did observe specific clinical changes.
March 2020 in “Annals of internal medicine” This summary from Annals for Educators discusses educational materials on a wide range of topics including methotrexate's adverse effects, therapies for cannabis use disorder, the Hamman sign in physical examination, emotional challenges in medical practice, and renal treatments in lupus nephritis, without providing new clinical results.
169 citations
,
August 2004 in “Baillière's best practice & research. Clinical obstetrics & gynaecology/Baillière's best practice and research in clinical obstetrics and gynaecology” This article discusses treatments for hirsutism and acne in women with polycystic ovary syndrome, suggesting that lower doses of current medications maintain efficacy while reducing cost and side effects, but reports no new clinical results.
1 citations
,
November 2008 in “Gerontology” This article discusses the increasing use of lifestyle drugs by healthy individuals to alter appearance or slow aging and emphasizes the need for doctors to consider side effects and contraindications, but it reports no new clinical findings.
September 2021 in “Journal of skin and stem cell” Lactium, a milk protein, can help reduce symptoms of skin disorders linked to stress and anxiety without side effects.
This paper discusses the traditional use of Siddha medicines for hair growth and treating hair loss, claiming they effectively address hair fall, baldness, and dandruff without side effects, potentially due to lifestyle factors like diet and stress influencing hair health through imbalances in "pitha.
February 1999 in “Strength and Conditioning Journal” Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.
49 citations
,
November 1992 in “Archives of dermatology” This article discusses the emotional and psychological impact of severe alopecia areata on patients, emphasizing feelings of loss, vulnerability, and self-identity changes, and reports no new results.
This study found that low-intensity light therapy improved quality of life related to emotional, psychosocial, and symptom domains in individuals with androgenic alopecia, with a greater impact observed in women.